This 1.5-hour, recorded course is part of an online case-based learning collaborative series and focuses on strategies to effectively manage medetomidine-opioid withdrawal syndrome.

The Benzodiazepine Tapering Considerations in General Medicine: Implementing The Joint Clinical Practice Guideline is a 4-hour course that translates the Joint Clinical Practice Guideline on Benzodiazepine Tapering into practical strategies for safer tapering.

This 88-hour on-demand conference includes 64 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 1 hour and 45-minute on-demand session from the ASAM 57th Annual Conference addresses benzodiazepine management in outpatient settings, applying ASAM guidelines to cases and exploring tapering strategies and success definitions.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses phenobarbital protocols for alcohol withdrawal through point-counterpoint debate, comparing pharmacologic strategies and institutional implementation approaches.

This 6-hour course is an interactive, case-based course designed for healthcare providers who work with patients taking benzodiazepines.

This one-hour, journal article-based activity explores the emerging clinical phenomenon of xylazine-related wounds among patients with substance use disorder. Using data from hospitalized patients in Philadelphia, the article examines patient demographics, substance use patterns, and wound characteristics associated with suspected xylazine exposure. Learners will review how these wounds present clinically, how they may differ from infectious skin and soft tissue conditions, and the challenges clinicians face in diagnosis and management. The activity also explores management considerations, including wound care approaches and antibiotic use, to support accurate recognition and evidence-informed clinical decision-making as xylazine-related presentations expand.

This 45-minute, on-demand session from the ASAM 2025 Review Course reviews the pharmacokinetics of sedatives, growing prevalence of sedative use, and discusses the risks and benefits of sedative use as well as treatment strategies for sedative withdrawal.

This one-hour, on-demand, journal article-based activity explores the rising US drug overdose death rate from 2002 to 2022, with a focus on the emerging role of kratom (mitragynine). Recent data on kratom detection in overdose cases provides consideration for how these findings can inform overdose prevention efforts and guide the development of targeted interventions.

This 75-hour on-demand conference includes 64 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.